Top Markets
Coin of the day
Mosaic ImmunoEngineering Inc. Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc.

CPMV
Clasificación en acciones #38778
Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to... Mosaic ImmunoEngineering Inc. is an early-stage biotechnology firm dedicated to the advancement and commercialization of an immunomodulatory platform technology. This innovative platform aims to provide therapeutic solutions for cancer and infectious diseases in both human and animal health. The company's core product is MIE-101, a nanoparticle-based treatment sourced from the cowpea mosaic virus, which has demonstrated non-infectious characteristics in mice, dogs, and humans. Headquartered in Novato, California, the company commenced operations in 2020.
Precio por acción
$0.106
Última sincronización: 2026-10-01
Capitalización bursátil
$767.67K
Cambio (1 día)
73.77%
Cambio (1 año)
-84.81%
País
US
Comercio Mosaic ImmunoEngineering Inc. (CPMV)

Categoría

Ratio P/B de Mosaic ImmunoEngineering Inc. (CPMV)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Mosaic ImmunoEngineering Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Mosaic ImmunoEngineering Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.5558 -
US
11.2791 -
US
4.0142 -
AU
7.082 -
NL
- -
CH